RLAY: Director Thomas Catinazzo executed 4 10b5-1 sales (Apr–May 2026)
Rhea-AI Filing Summary
Form 144 sale notice: A Form 144 filing related to RLAY lists intended dispositions of Common stock and shows multiple 10b5-1 sales executed by Thomas J. Catinazzo. The filing itemizes planned methods (including exercise of stock options) and records four recent 10b5-1 sales on 04/07/2026, 04/09/2026, 04/28/2026, and 05/14/2026 with the share counts and proceeds shown below.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 resale notice with documented 10b5-1 activity.
The filing lists intended dispositions of Common stock tied to option exercises and equity awards, and it documents four 10b5-1 sales by Thomas J. Catinazzo in April–May 2026. The excerpt provides exact per‑trade share counts and proceeds for those sales.
Cash‑flow treatment and any issuer proceeds for the planned dispositions are not described in the excerpt; subsequent filings or company disclosures could clarify whether the issuer receives proceeds from any listed transactions.
Key Figures
Key Terms
10b5-1 regulatory
Restricted Stock Units financial
Performance Stock Units financial
Form 144 regulatory
FAQ
How many recent 10b5-1 sales are shown and who executed them?
Does the Form 144 show who receives the sale proceeds?
Are restricted or performance awards referenced in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.